Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature

Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature

Lei Deng,1 Janaki Sharma,2 Elizabeth Ravera,2 Balazs Halmos,2 Haiying Cheng2 1Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA; 2Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA Abstract: Alectinib...

Full description

Bibliographic Details
Main Authors: Deng L, Sharma J, Ravera E, Halmos B, Cheng H
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Lung Cancer : Targets and Therapy
Subjects:
Hypersensitivity
ALK
alectinib
brigatinib
lung cancer
Online Access:https://www.dovepress.com/hypersensitivity-in-alk-positive-lung-cancers-exposed-to-alk-inhibitor-peer-reviewed-article-LCTT

Internet

https://www.dovepress.com/hypersensitivity-in-alk-positive-lung-cancers-exposed-to-alk-inhibitor-peer-reviewed-article-LCTT

Similar Items